Neo Kuma Ventures

Neo Kuma Ventures is a venture capital firm established in 2020 and based in London, United Kingdom. It is recognized as one of the pioneering firms dedicated exclusively to investing in companies within the psychedelic medicine space. The firm focuses on sectors such as psychedelic-therapeutic compounds, clinics and care delivery, and digital therapeutics, primarily targeting opportunities in European countries. Neo Kuma Ventures has already made several investments and is actively working on additional opportunities as it approaches the close of its first fund.

Fergus Argyle

Investor

Clara Burtenshaw

Co-Founder, Investor and Partner

Sean McLintock

Co-Founder, Investor and Partner

5 past transactions

Syndi

Pre Seed Round in 2023
Syndi is a digital health platform that focuses on enhancing health outcomes through technology and research, initially targeting mental health. The platform employs machine learning and digital phenotyping to provide personalized and immediate care by utilizing moment-by-moment passive smartphone data collection. This approach allows for effective and accessible support tailored to individual needs. Syndi's services aim to improve the treatment of invisible disabilities by facilitating connections between patients and healthcare providers, while also measuring the effectiveness of its applications and digital services. Through its innovative solutions, Syndi seeks to transform the way people access and engage with healthcare.

Fluence

Seed Round in 2021
Fluence provides educational programs focused on psychedelic integration and psychedelic-assisted therapy, aimed at licensed professionals and advanced graduate students. The organization offers continuing education and certification courses that enhance the skills and knowledge of healthcare workers, enabling them to deliver effective and compassionate psychedelic therapy. While there are no specific prerequisites for enrollment, a foundational understanding of the mental health field is beneficial. The programs are interactive, incorporating discussions, demonstrations, self-reflection exercises, and role plays to facilitate learning. Although some classes are exclusively for licensed clinicians, many programs are accessible to a broader audience interested in the subject.

wavepaths

Seed Round in 2021
Wavepaths creates accessible tools, that deepen their connection with ourselves and others, and expand their potential to have life changing experiences.

Journey Clinical

Seed Round in 2021
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care.

Tripp

Series A in 2021
TRIPP Inc. is a company that specializes in developing virtual reality experiences aimed at enhancing emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a development office in Chicago, TRIPP combines audio-visual elements, gameplay mechanics, and meditation to create immersive experiences that positively influence mood and mental states. Drawing on research indicating that interactive digital experiences can affect brain function, TRIPP positions itself as a pioneer in the intersection of gaming and mindfulness. By leveraging their expertise in game design, the company seeks to redefine the traditional notion of gaming, focusing on the potential of their products to serve as tools for emotional transformation rather than mere entertainment. Ultimately, TRIPP aims to help users achieve desired emotional states, fostering a unique mind-body connection through their innovative offerings.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.